Literature DB >> 33580439

Targeting Mitochondrial Dysfunction for Bipolar Disorder.

Maya Kuperberg1, Sophie L A Greenebaum2, Andrew A Nierenberg3,4.   

Abstract

People with bipolar disorder (BD) all too often have suboptimal long-term outcomes with existing treatment options. They experience relapsing episodes of depression and mania and also have interepisodic mood and anxiety symptoms. We need to have a better understanding of the pathophysiology of BD if we are to make progress in improving these outcomes. This chapter will focus on the critical role of mitochondria in human functioning, oxidative stress, and the biological mechanisms of mitochondria in BD. Additionally, this chapter will present the evidence that, at least for some people, BD is a product of mitochondrial dysregulation. We review the modulators of mitochondria, the connection between current BD medication treatments and mitochondria, and additional medications that have theoretical potential to treat BD.

Entities:  

Keywords:  Bipolar disorder; Medication; Mitochondria; Treatment

Mesh:

Year:  2021        PMID: 33580439     DOI: 10.1007/7854_2020_152

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  193 in total

Review 1.  Systematic review and meta-analysis of randomized placebo-controlled trials of folate and vitamin B12 for depression.

Authors:  Osvaldo P Almeida; Andrew H Ford; Leon Flicker
Journal:  Int Psychogeriatr       Date:  2015-02-03       Impact factor: 3.878

2.  Exploring the relationship between vitamin D and mania: correlations between serum vitamin D levels and disease activity.

Authors:  Neslihan Altunsoy; Rabia Nazik Yüksel; Merve Cingi Yirun; Ayşegül Kılıçarslan; Çiğdem Aydemir
Journal:  Nord J Psychiatry       Date:  2018-01-07       Impact factor: 2.202

3.  Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.

Authors:  Ana C Andreazza; Li Shao; Jun-Feng Wang; L Trevor Young
Journal:  Arch Gen Psychiatry       Date:  2010-04

Review 4.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

Review 5.  Melatonin role in the mitochondrial function.

Authors:  Dario Acuna-Castroviejo; Germaine Escames; Maria I Rodriguez; Luis C Lopez
Journal:  Front Biosci       Date:  2007-01-01

Review 6.  Clinical syndromes associated with Coenzyme Q10 deficiency.

Authors:  María Alcázar-Fabra; Eva Trevisson; Gloria Brea-Calvo
Journal:  Essays Biochem       Date:  2018-07-20       Impact factor: 8.000

Review 7.  Can lactate serve as an energy substrate for axons in good times and in bad, in sickness and in health?

Authors:  Selva Baltan
Journal:  Metab Brain Dis       Date:  2014-07-19       Impact factor: 3.584

Review 8.  One-carbon metabolism and bipolar disorder.

Authors:  Ji Hyun Baek; Emily E Bernstein; Andrew A Nierenberg
Journal:  Aust N Z J Psychiatry       Date:  2013-08-22       Impact factor: 5.744

9.  The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder.

Authors:  Süleyman Akarsu; Abdullah Bolu; Emre Aydemir; Selma Bozkurt Zincir; Yasemin Gülcan Kurt; Serkan Zincir; Murat Erdem; Özcan Uzun
Journal:  Psychiatry Investig       Date:  2018-04-20       Impact factor: 2.505

Review 10.  The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment.

Authors:  A H Ashok; T R Marques; S Jauhar; M M Nour; G M Goodwin; A H Young; O D Howes
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

View more
  4 in total

Review 1.  Comparative efficacy of mitochondrial agents for bipolar disorder during depressive episodes: a network meta-analysis using frequentist and Bayesian approaches.

Authors:  Rituparna Maiti; Archana Mishra; Biswa Ranjan Mishra; Monalisa Jena
Journal:  Psychopharmacology (Berl)       Date:  2021-11-09       Impact factor: 4.415

Review 2.  Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder.

Authors:  Sahithi Madireddy; Samskruthi Madireddy
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

3.  Associations between levels of oxidative nucleoside damage and cardiovascular risk in patients newly diagnosed with bipolar disorder and their unaffected relatives.

Authors:  Helena Lykke Bøgh; Sharleny Stanislaus; Hanne Lie Kjærstad; Kimie Stefanie Ormstrup Sletved; Julie Lyng Forman; Henrik Enghusen Poulsen; Maj Vinberg; Lars Vedel Kessing; Klara Coello
Journal:  Transl Psychiatry       Date:  2022-08-10       Impact factor: 7.989

4.  Selective serotonin reuptake inhibitor citalopram ameliorates cognitive decline and protects against amyloid beta-induced mitochondrial dynamics, biogenesis, autophagy, mitophagy and synaptic toxicities in a mouse model of Alzheimer's disease.

Authors:  Arubala P Reddy; Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Lloyd E Bunquin; Xiangling Yin; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2021-05-28       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.